Northeast Financial Consultants Inc Purchases New Stake in The Clorox Company (NYSE:CLX)

Northeast Financial Consultants Inc acquired a new stake in shares of The Clorox Company (NYSE:CLX) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,312 shares of the company’s stock, valued at approximately $214,000.

Other hedge funds also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter worth about $27,000. Innealta Capital LLC bought a new stake in Clorox in the second quarter valued at about $30,000. Trifecta Capital Advisors LLC raised its stake in Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares in the last quarter. Family Firm Inc. bought a new position in Clorox during the 2nd quarter worth approximately $31,000. Finally, Quarry LP grew its position in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX stock opened at $166.97 on Friday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a market capitalization of $20.67 billion, a price-to-earnings ratio of 58.18, a price-to-earnings-growth ratio of 3.10 and a beta of 0.42. The business has a 50 day simple moving average of $163.50 and a 200 day simple moving average of $150.49.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the business posted $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. Clorox’s dividend payout ratio (DPR) is 170.04%.

Analyst Upgrades and Downgrades

CLX has been the topic of several research reports. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their price target for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, Barclays increased their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. Five analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.